143 related articles for article (PubMed ID: 31509481)
1. Practice-Level Adoption of Conservative Management for Prostate Cancer.
Modi PK; Kaufman SR; Herrel LA; Dupree JM; Luckenbaugh AN; Skolarus TA; Hollenbeck BK; Shahinian VB
J Oncol Pract; 2019 Oct; 15(10):e863-e869. PubMed ID: 31509481
[TBL] [Abstract][Full Text] [Related]
2. Urologist Practice Structure and Spending for Prostate Cancer Care.
Modi PK; Herrel LA; Kaufman SR; Yan P; Borza T; Skolarus TA; Schroeck FR; Hollenbeck BK; Shahinian VB
Urology; 2019 Aug; 130():65-71. PubMed ID: 31029672
[TBL] [Abstract][Full Text] [Related]
3. Health care delivery system contributions to management of newly diagnosed prostate cancer.
Krampe N; Kaufman SR; Oerline MK; Hill D; Caram MEV; Shahinian VB; Hollenbeck BK; Maganty A
Cancer Med; 2023 Aug; 12(16):17346-17355. PubMed ID: 37475511
[TBL] [Abstract][Full Text] [Related]
4. Urology Workforce Changes and Implications for Prostate Cancer Care Among Medicare Enrollees.
Marchetti KA; Oerline M; Hollenbeck BK; Kaufman SR; Skolarus TA; Shahinian VB; Caram MEV; Modi PK
Urology; 2021 Sep; 155():77-82. PubMed ID: 33610652
[TBL] [Abstract][Full Text] [Related]
5. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly.
Hollenbeck BK; Kaufman SR; Yan P; Herrel LA; Borza T; Schroeck FR; Jacobs BL; Skolarus TA; Shahinian VB
Eur Urol; 2018 Apr; 73(4):491-498. PubMed ID: 28823605
[TBL] [Abstract][Full Text] [Related]
6. The Influence of Practice Structure on Urologists' Treatment of Men With Low-Risk Prostate Cancer.
Mitchell JM; Gresenz CR
Med Care; 2022 Sep; 60(9):665-672. PubMed ID: 35880758
[TBL] [Abstract][Full Text] [Related]
7. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
[TBL] [Abstract][Full Text] [Related]
8. Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States.
Shelton JB; Buffington P; Augspurger R; Gaylis F; Cohen T; Mehlhaff B; Suh R; Bradford TJ; Kwan L; Koo AS; Shore N
Urology; 2019 Jul; 129():79-86. PubMed ID: 30954610
[TBL] [Abstract][Full Text] [Related]
9. Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities.
Agochukwu-Mmonu N; Qin Y; Kaufman S; Oerline M; Vince R; Makarov D; Caram MV; Chapman C; Ravenell J; Hollenbeck BK; Skolarus TA
JCO Oncol Pract; 2023 May; 19(5):e763-e772. PubMed ID: 36657098
[TBL] [Abstract][Full Text] [Related]
10. Urologist practice divestment from radiation vault ownership and treatment patterns for prostate cancer.
Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline MK; Caram MEV; Shahinian VB; Hollenbeck BK
Cancer; 2024 May; 130(9):1609-1617. PubMed ID: 38146764
[TBL] [Abstract][Full Text] [Related]
11. Practice Competition and Treatment of Newly Diagnosed Prostate Cancer.
Maganty A; Hollenbeck BK; Kaufman SR; Oerline MK; Lai LY; Caram MEV; Shahinian VB
Urology; 2023 Jul; 177():95-102. PubMed ID: 37146728
[TBL] [Abstract][Full Text] [Related]
12. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
[TBL] [Abstract][Full Text] [Related]
13. Differences in practice patterns between urologists and radiation oncologists in the management of localized prostate cancer: a cross-sectional survey.
Ariane MM; Ploussard G; Rebillard X; Malavaud B; Rischmann P; Hennequin C; Mongiat-Artus P
World J Urol; 2015 Nov; 33(11):1741-7. PubMed ID: 25822706
[TBL] [Abstract][Full Text] [Related]
14. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: an ecological study.
Hjertholm P; Fenger-Grøn M; Vestergaard M; Christensen MB; Borre M; Møller H; Vedsted P
Int J Cancer; 2015 Jan; 136(2):435-42. PubMed ID: 24905402
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Conservative Management Compared to Cryotherapy in Localized Prostate Cancer Patients.
Shah S; Young HN; Cobran EK
Am J Mens Health; 2018 Sep; 12(5):1681-1691. PubMed ID: 29877137
[TBL] [Abstract][Full Text] [Related]
16. Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016.
Ong WL; Evans SM; Evans M; Tacey M; Dodds L; Kearns P; Milne RL; Foroudi F; Millar J
Eur Urol Oncol; 2021 Apr; 4(2):319-322. PubMed ID: 31411964
[TBL] [Abstract][Full Text] [Related]
17. The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer.
Faraj KS; Kaufman SR; Herrel LA; Maganty A; Oerline M; Caram MEV; Shahinian VB; Hollenbeck BK
Cancer Med; 2023 Dec; 12(24):22325-22332. PubMed ID: 38100144
[TBL] [Abstract][Full Text] [Related]
18. Understanding Active Surveillance for Prostate Cancer.
Lai LY; Shahinian VB; Oerline MK; Kaufman SR; Skolarus TA; Caram MEV; Hollenbeck BK
JCO Oncol Pract; 2021 Nov; 17(11):e1678-e1687. PubMed ID: 33830822
[TBL] [Abstract][Full Text] [Related]
19. Association between urologist characteristics and radiation oncologist consultation for patients with locoregional prostate cancer.
Quek RG; Ward KC; Master VA; Lin CC; Portier KM; Virgo KS; Lipscomb J
J Natl Compr Canc Netw; 2015 Mar; 13(3):303-9. PubMed ID: 25736007
[TBL] [Abstract][Full Text] [Related]
20. Nine-year prostate cancer survival differences between aggressive versus conservative therapy in men with advanced and metastatic prostate cancer.
Dall'Era MA; Lo MJ; Chen J; Cress R; Hamilton AS
Cancer; 2018 May; 124(9):1921-1928. PubMed ID: 29499075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
